1. Home
  2. Animal Drug Index - V
  3. Veterinary 5% Dextrose

Animal NDC 50989-896-17 Veterinary 5% Dextrose

Dextrose

Animal Product Information

Field Name Field Value
Animal NDC Code 50989-896-17
Proprietary Name Veterinary 5% Dextrose What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
Non-Proprietary Name Dextrose What is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
Labeler Name Vedco, Inc.
Product Type Prescription Animal Drug
Usage Information
    5% Dextrose Injection, USP is indicated as a source of water and calories
Active Ingredient(s)
  • Dextrose Monohydrate
Inactive Ingredient(s)
  • WATER (059QF0KO0R)
  • WATER (059QF0KO0R)
Marketing Category UNAPPROVED DRUG OTHER What is the Marketing Category?
Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Veterinary 5% Dextrose Images

Veterinary 5% Dextrose Animal Product Labeling Information

The product labeling information includes all published material associated to a drug. Product labeling documents include information like generic names, active ingredients, ingredient strength dosage, routes of administration, appearance, usage, warnings, inactive ingredients, etc.

Table of Contents



Description



5% Dextrose Injection, USP is a sterile, nonpyrogenic solution for fluid and electrolyte replenishment in single dose containers for intravenous administration. It contains no antimicrobial agents or preservatives. Discard unused portion. Composition, osmolarity, and ionic concentration are shown in Table 1:


Clinical Pharmacology



5% Dextrose Injection, USP has value as a source of water and calories. It is capable of inducing diuresis, depending on the clinical condition of the patient.


Indications And Usage



5% Dextrose Injection, USP is indicated as a source of water and calories


Contraindications




Solutions containing dextrose my be contraindicated in patients with known allergy to corn or corn products



Warnings



5% Dextrose Injection, USP should not be administered simultaneously with blood through the same administration set because of the possibility of pseudoagglutination or hemolysis

The intravenous administration of 5% Dextrose Injection, USP can cause fluid and/or solute overloading resulting in dilution of serum electrolyte concentrations, over hydration, congested states, or pulmonary edema. The risk of dilutional states is inversely proportional to the electrolyte concentration of the injections. The risk of solute overload causing congested states with peripheral and pulmonary edema is directly proportional to the electrolyte concentrations of the injections.

Excessive administration of dextrose injection may result in significant hypokalemia



Adverse Reactions



Reactions which may occur because of the solution or the technique of administration include febrile response, infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection, extravasation, and hypervolemia. If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate therapeutic countermeasures and save the remainder of the fluid for examination if deemed necessary.


Precautions



Clinical evaluation and periodic laboratory determinations are necessary to monitor changes in fluid balance, electrolyte concentrations, and acid base balance during prolonged parenteral therapy or whenever the condition of the patient warrants such evaluation.

5% Dextrose Injection,USP must be used with caution in patients with overt or subclinical diabetes mellitus.

Do not administer unless solution is clear and seal is intact.


Dosage And Administration



As directed by a veterinarian. Dosage is dependent upon the age, weight and clinical condition of the patient, as well as laboratory determinations.

Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit.

All solutions for injections in plastic containers are intended for intravenous administration using sterile equipment and aseptic technique.

Additives may be incompatible. Complete information is not available. Those additives known to be incompatible should not be used. Consult with pharmacist, if available. If, in the informed judgment of the veterinarian, it is deemed advisable to introduce additives, use aseptic technique. Mix thoroughly when additives have been introduced. Do not store solutions containing additives. Discard unused portion.


Over Dosage



In an event of over hydration or solute overload, re-evaluate the patient and institute appropriate corrective measures. See Warnings. Precautions and Adverse Events.


How Supplied



Veterinary 5% Dextrose Injection, USP in plastic container is available as follows:

Plastic Container:

PVC Free, DEHP Free, Latex Free


Storage:



Exposure of pharmaceutical products to heat should be minimized. Avoid excessive heat. It is recommended the product be stored in the moisture overwrap at room temperature (25°C/77°F); brief exposure up to (40°C/104°F) does not adversely affect the product.



Directions For Use Of Plastic Container



To Open

Tear overwrap down side at slit and remove solution container.  Some opacity of the plastic due to moisture absorption during the sterilization process may be observed.  This is normal and does not affect the solution quality or safety. The opacity will diminish gradually.  Check for minute leaks by squeezing inner bag firmly.  If leaks are found, discard solution as sterility may be impaired.  If supplemental medication is desired, follow directions below.

Preparation for Administration

1.  Suspend container from eyelet support.

2.  Remove protector from outlet port at bottom of container.

3.  Attach administration set.  Refer to complete directions accompanying set.

To Add Medication

WARNING:  Additives may be incompatible.

To add medication before solution administration

1.  Prepare medication site.

2.  Using syringe with 19 to 22 gauge needle, puncture resealable medication port and inject.

3.  Mix solution and medication thoroughly. For high density medication such as potassium chloride, squeeze ports while ports are upright and mix thoroughly.

To add medication during solution administration

1.  Close clamp on the set.

2.  Prepare medication site.

3.  Using syringe with 19 to 22 gauge needle, puncture resealable medication port and inject.

4.  Remove container from IV pole and/or turn to an upright position.

5.  Evacuate both ports by squeezing them while container is in the upright position.

6.  Mix solution and medication thoroughly.

7.  Return container to in-use position and continue administration.


CAUTION:  Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Manufactured for

Vedco, Inc.

5503 Corporate Dr.

St. Joseph, MO 64507  USA

Printed in El Salvador

For a copy of the Safety Data Sheet (SDS) or to report adverse reactions call Vedco, Inc. customer service at 1(888) 708-3326

© 2015 Vedco, Inc.


Principal Display Panel



NDC 50989-896-17

BIOGALENIC VEDCO

Veterinary 5% Dextrose for Injection, USP


* The information on this page is for an ANIMAL PRODUCT, please review the complete disclaimer below.